Conclusions and lessons learned
About This Webcast
Evidence in Action: HCP Advisory Board Series brings together a select group of clinical leaders to provide real-world perspectives on the integration of device-based therapies and pharmaceuticals. Through a series of case-driven discussions, advisors will help shape future innovation, identify care gaps, and guide strategies that reflect current practice realities. This closed, expert-only forum fosters deep collaboration between healthcare professionals and the industry to ensure solutions are evidence-aligned and clinically relevant.
Speakers
Dr. Hadley Morgan, Ph. D.
Chief Scientist , Driver Scientific
Dr. Hadley Morgan is a distinguished figure in the pharmaceutical industry. With over two decades of experience, Dr. Morgan has forged an impressive career characterized by groundbreaking research.
Dr. Sandra Wu, MD, Ph. D.
Director of Obesity Medicine , Oklahoma University
I am the Director of Obesity Medicine at OU where I founded the Obesity Medicine clinical curriculum. I work with students and residents across primary care. My research interests focus on the neurophysiologic effects of AOMs and newincretintherapies.